Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

On the Convergence of Maximum Likelihood Expectation-maximization Algorithm for Iterative Tomographic Reconstruction and the Role of Spatial Frequency, Location, Pixel Intensity, Contrast, and Noise.

Journal of medical physics·2026
Same author

Truncation Artifact Presenting as Cropped Projections and Wedge Defect in Sinogram During Single-Photon Emission Computed Tomography.

Molecular imaging and radionuclide therapy·2025
Same author

Solar-assisted tri-generation system with LCPV‑CPC and small-scale gas turbine for year-round clean energy in hot-dry climates.

Scientific reports·2025
Same author

Local distortion as a pitfall of iterative MLEM reconstruction in myocardial perfusion imaging - A phantom study.

Journal of applied clinical medical physics·2025
Same author

Predictive optimization using long short-term memory for solar PV and EV integration in relatively cold climate energy systems with a regional case study.

Scientific reports·2025
Same author

Free-space optical spiking neural network.

PloS one·2025

相关实验视频

Updated: Jul 2, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.2K

从前列腺癌的皮肤转移在治疗后 177 Lu-前列腺特异性膜抗原扫描.

Mohammad Taghavi1, Reyhane Ahmadi2, Mohsen Qutbi3

  • 1From the Hegmataneh Nuclear Medicine Center.

Clinical nuclear medicine
|February 27, 2024
PubMed
概括

这项研究介绍了一名患有扩散转移的前列腺癌患者,他接受了Lutetium-177前列腺特异性膜抗原 (177Lu-PSMA) 治疗. 治疗揭示了胸壁上新的皮肤转移性病变.

更多相关视频

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.1K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.3K

相关实验视频

Last Updated: Jul 2, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.2K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.1K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.3K

科学领域:

  • 在瘤学瘤学.
  • 核医学就是核医学.
  • 放射性药物疗法是一种放射性药物疗法.

背景情况:

  • 前列腺癌 (PCa) 是全球癌症死亡的主要原因.
  • 转移性前列腺癌通常会扩散到骨和肝脏.
  • 化学辐射疗法是晚期PCa的标准治疗方法.

研究的目的:

  • 报告一个前列腺癌病例与广泛的骨和肝脏转移.
  • 在这个患者177Lu-前列腺特异性膜抗原 (177Lu-PSMA) 治疗后,描述成像发现.
  • 为了突出发现胸壁上的皮肤转移性病变.

主要方法:

  • 一名已知患有前列腺癌和广泛转移的患者接受了化疗放射治疗.
  • 随后,该患者接受了两剂177 Lu-PSMA疗法.
  • 进行诊断成像,以评估治疗反应和疾病进展.

主要成果:

  • 在177次Lu-PSMA治疗后,在胸壁上检测到几个吸收区域.
  • 这些吸收区域与前列腺癌的皮肤转移性病变一致.
  • 这些发现表明,177 Lu-PSMA成像可以识别以前未被检测到的皮肤转移.

结论:

  • 177 Lu-PSMA治疗可以揭示晚期前列腺癌中的皮肤转移性病变.
  • 这一案例强调了177Lu-PSMA治疗在识别各种转移部位方面的实用性.
  • 需要进一步的研究来探索177 Lu-PSMA成像检测到的皮肤转移的临床意义.